Target intelligence / Profile preview

Tyramine oxidase (tynA) (tynA)

Target
tynA
Molecular classification
Enzyme, Oxidoreductase, Copper-containing amine oxidase
01

Overview

Tyramine oxidase (TynA) is a copper-containing enzyme primarily characterized in bacteria such as Escherichia coli, where it facilitates the oxidative deamination of primary amines like tyramine and phenylethylamine [UniProt P0AEC8, PMID: 1353444]. This enzymatic reaction produces the corresponding aldehyde, ammonia, and hydrogen peroxide, enabling the bacterium to utilize amines as a nitrogen source [PMID: 9461325]. TynA belongs to the family of copper-containing amine oxidases (CuAOs) and utilizes a unique, protein-derived cofactor known as topaquinone (TPQ), which is formed by the post-translational modification of a specific tyrosine residue [PMID: 10521336]. While TynA itself is not a common target for human clinical therapeutics, it is extensively studied as a structural and functional model for human CuAOs, including vascular adhesion protein-1 (VAP-1/AOC3) and diamine oxidase (DAO/AOC1) [PMID: 11932214]. Inhibitors of TynA, such as various hydrazine derivatives and semicarbazide, are used in research to explore the mechanisms of amine oxidation and to develop selective inhibitors that could potentially target related enzymes involved in human inflammatory and metabolic diseases [ChEMBL CHEMBL2595, PMID: 1353444].

Other names
Copper-containing amine oxidasePhenylethylamine oxidaseCuAOPrimary-amine:oxygen oxidoreductase (deaminating) (copper-containing)Bacterial monoamine oxidase
02

Mechanism of action

Covalent inhibition of the topaquinone (TPQ) cofactor

03

Biological functions

Amine metabolismNitrogen utilizationOxidation-reduction process
04

Disease associations

InfectionOther (Biogenic amine toxicity)
05

Safety considerations

Off-target inhibition of human amine oxidases (e.g., MAO-A, MAO-B, AOC3)Potential for hypertensive crisis (cheese effect) if human MAO is cross-inhibited
06

Interacting drugs

Semicarbazide

3 more in the full profile.

07

Biomarkers

Tyramine levelsPhenylethylamine levelsHydrogen peroxide production

Beyond the preview

Go deeper on Tyramine oxidase (tynA) (tynA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyramine oxidase (tynA) (tynA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call